StreetAlpha.app
Home › Stocks › ASST

Strive, Inc. (ASST)

Communication Services
$14.51
▼ −12.64%
LAST CLOSE · NOV 20

Strive is a finance company and asset manager that holds bitcoin and sells health technology products through Semler Scientific. It last closed at $14.51 on Nov 20, down 12.64% on the day. The next earnings report for ASST is expected around Thu, Mar 18, 2027. For the quarter ended Sep 2026, ASST reported EPS of $5.24 on revenue of $2.7M. Over its last 8 reports the stock moved an average of 5.4% the session after earnings. Over the last 12 months ASST insiders bought $1.3M of stock on the open market and sold $3.2M, according to SEC Form 4 filings.

AI Auto Pilots
Is ASST in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ASST.

Key Stats

Last 12 months
Results
Revenue
$9.7M
Net income
−$215.8M
−2235.2% margin
EPS (diluted)
−$7.69
Operating margin
−2697.6%
−$260.4M operating income
Balance sheet
Cash & equivalents
$285.4M
At Sep 30
Shareholder equity
$1.4B
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $830K$830KFY2021FY2022: $343K$343KFY2022FY2023: $277K$277KFY2023FY2024: $3.6M$3.6MFY2024

From ASST's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Mar 18
Estimated date · Time not announced
Reported EPS
$5.24
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
$2.7M
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Sep 2024: -$3.06Sep '24Dec 2024: -$1.82Dec '24Mar 2025: -$1.65Mar '25Jun 2025: -$3.86Jun '25Dec 2025: -$4.63Dec '25Mar 2026: -$4.53Mar '26Jun 2026: -$3.77Jun '26Sep 2026: $5.24Sep '26Latest $5.24
Revenue by quarter
Sep 2024: $984,000Sep '24Dec 2024: $1.0MDec '24Mar 2025: $1.4MMar '25Jun 2025: $1.5MJun '25Dec 2025: $1.3MDec '25Mar 2026: $2.8MMar '26Jun 2026: $2.9MJun '26Sep 2026: $2.7MSep '26Latest $2.7M
How ASST moved after its last 8 reports
Average move the session after a report ±5.4%
Nov 6, 2026Time not announced+4.2%
Aug 10, 2026Time not announced−0.3%
May 14, 2026Time not announced+5.8%
Mar 19, 2026Time not announced+2.2%
Jan 5, 2026Time not announced+19.1%
Nov 14, 2025After the close−3.7%
Oct 2, 2025Time not announced+6.0%
Nov 15, 2024Time not announced+2.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ASSTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ASST
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ASST

Technical Analysis

ASST · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold

The stock is 48% below its 20 day and 77% below its 50 day average. It is 15% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $13.70, and the nearest resistance the Pivot at $15.16.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 14.5%/day
Key levels
$32.0852 week high+121.1%
$25.6650 day average+76.8%
$21.4820 day average+48.0%
$20.81100 day average+43.4%
$17.57Swing high (Jun 15)+21.1%
$16.75200 day average+15.4%
$15.96Pivot R1+10.0%
$15.16Pivot+4.5%
$14.51Last close
$13.70Pivot S1−5.6%
$13.39Swing low (Jun 5)−7.7%
$7.0252 week low−51.6%
Indicators
RSI (14)26.86Oversold below 30Oversold
MACD-2.48Below its signal lineBearish
Stochastic1.1Near the bottom of its rangeOversold
ADX (14)21.6Weak trend
Williams %R-98.3Oversold below −80, overbought above −20Oversold
CCI (20)-182.5Oversold below −100, overbought above 100Oversold
Rate of change−32.4%Change over 10 sessionsBearish
ATR (14)$2.10Typical daily range, 14.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ASST

What happened before

See how ASST did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ASST usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ASST has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ASSTHow many large options trades hit ASST, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

ASST Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲134 buying vs 80 selling
  • ▲Shares held by funds +5.8%
  • ▲Funds holding +26
  • ▼Superinvestors: 1 added, 2 cut
  • ▲Put/call 0.89 to 0.57
Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding200174+14.9%
In funds' top 1032+50.0%
Held by funds–––
New / increased58 / 7658 / 73+2.3%
Reduced / sold out46 / 3423 / 21+81.8%
Put/call ratio0.570.89−35.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ASST institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ASST Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$1.3M5 buys · 4 insiders
Sold$3.2M6 sales · 6 insiders
Cluster buy: 2 insiders bought $215K between Feb 13 and Feb 18.
2025-12 bought $417K2026-01 bought $460K2026-02 bought $215K2026-08 bought $199K2026-10 sold $3.2MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Oct 5Arshia SarkhaniChief Marketing OfficerSale5,634$31.33$177K
Oct 5Brian Logan BeirneChief Legal OfficerSale20,077$31.33$629K
Oct 5James LavishDirectorSale6,000$30.75$185K
Oct 5Jonathan R MaceyDirectorSale6,700$30.32$203K
Oct 5Matthew Ryan ColeCEOSale58,789$31.33$1.8M
Oct 5Benjamin PhamCFOSale4,209$31.33$132K
Every insider buy and sale for ASST over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ASST insider trades →

From SEC Form 4 filings by ASST's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASST is in one of them and how their past ASST trades turned out.

ASST in the AI portfolios
Loading…

ASST News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ASST in an article yet. Here's the latest on the wider market.

ASST in the news

About Strive

Strive is a structured finance company and institutional asset manager based in Dallas, Texas. It earns fees from the assets it manages and holds bitcoin as a treasury reserve. Through its acquisition of Semler Scientific, it also sells technology products and services that help customers evaluate and treat chronic diseases.

Headquarters
Dallas, TX